Zimmer Biomet
Zimmer Biomet Holdings, Inc. is a global leader in the musculoskeletal healthcare industry, formed by the merger of Zimmer Holdings and Biomet. Based in Warsaw, Indiana, the company specializes in providing a comprehensive suite of products and services for orthopedic surgery, including joint replacement, trauma, and sports medicine. In the Joint Replacement Devices market, Zimmer Biomet holds the top position, driven by its extensive portfolio covering hip, knee, and shoulder systems. Key offerings include the Zimmer TKA and Zimmer TKR systems, known for their durability and flexible surgical compatibility. The company is actively integrating digital health and enabling technology through its ZBEdge suite, which includes the ROSA Robotic-Assisted Surgery platform for both knee and hip procedures. Furthermore, Zimmer Biomet pioneered the Persona IQ, reportedly the first FDA-cleared smart knee that measures patient activity post-surgery, demonstrating its commitment to innovation in patient care and functional outcomes.
Latest Market Research Report on Joint Replacement Devices Download PDF Brochure Now
Stryker
Stryker Corporation is a leading medical technology company headquartered in Kalamazoo, Michigan, renowned for its innovative products and services across orthopedics, medical, and surgical sectors. Stryker is one of the dominant players in the joint replacement market, consistently ranking among the top companies globally. Its significant success and growth are largely attributed to the pioneering Mako SmartRobotics™ system, a cutting-edge platform that provides surgeons with highly precise, robotic-assisted surgical planning and execution for hip and knee replacements. This enabling technology is considered a key differentiator and a primary driver of Stryker’s international sales growth. Beyond robotics, the company offers a comprehensive portfolio of knee replacement systems, an improved hip portfolio, and a leading shoulder business, supported by proprietary technologies like the Triathlon Total Knee and a strong global distribution network. Stryker’s strategy focuses on integrating technology and high-quality implants to optimize surgical outcomes and hospital efficiency.
Johnson & Johnson (DePuy Synthes)
Johnson & Johnson MedTech, through its DePuy Synthes division, stands as a major force in the global joint replacement market, known for its deep history of innovation and wide array of orthopedic solutions. DePuy Synthes is highly regarded for manufacturing top-tier orthopedic implants and surgical technologies, including the widely trusted ATTUNE® Knee Systems and the CORAIL® Hip Systems. The company is committed to advancing personalized, data-driven joint restoration by pioneering minimally invasive approaches and utilizing advanced biomaterials. A key element of its recent strategy is the deployment of the VELYS Robotic-Assisted Solution, which provides surgeons with critical real-time data during total knee replacement procedures, helping to enhance precision and improve patient outcomes. Its strong global presence and deep integration within the broader Johnson & Johnson healthcare ecosystem solidify its standing as one of the “Big Four” leaders in the joint replacement industry.
Smith & Nephew
Smith & Nephew plc is a global medical technology company based in London, UK, with a history spanning over 160 years, maintaining a strong position in the joint replacement market, particularly through its Orthopaedics segment. The company specializes in developing and marketing advanced hip and knee prostheses, known for leveraging innovative ceramic and advanced polymer materials designed for longevity and biocompatibility. Smith & Nephew is a key provider of solutions focused on minimally invasive surgical techniques and is active in the growing trend toward outpatient arthroplasty, positioning itself as a partner for high-volume ambulatory centers seeking cost-effective, rapid-recovery solutions. While historically part of the “Big Four,” the company is actively pursuing operational improvements to counter market challenges and maintain its global market presence in joint reconstruction and sports medicine, including expanding its own robotics portfolio.
B. Braun (Aesculap)
B. Braun Melsungen AG is a leading German manufacturer and healthcare provider, operating globally, with its Aesculap division specifically focused on delivering high-quality and precise orthopedic surgical solutions. Aesculap is a significant player in the international joint replacement market, known for its portfolio of hip and knee systems that emphasize modularity, reliability, and cost-effectiveness. The company’s products are often valued in public and institutional healthcare settings due to their focus on safe, standardized procedures and robust aftersales support. Aesculap has recently engaged in strategic international cooperation agreements, such as partnering for the development of antimicrobial-coated revision implants for both knee and hip systems. While it pulled its hip and knee portfolios from the U.S. market in 2024, its products continue to drive meaningful growth in European and Latin American markets, reinforcing its status as a trusted name in joint replacement outside the U.S.
Exactech
Exactech, Inc. is a rapidly growing medical technology company specializing in the design and manufacture of joint replacement implants and surgical instrumentation for the hip, knee, and shoulder. Exactech distinguishes itself by focusing on user-friendly, streamlined instrumentation and highly modular implant systems, which are designed to enhance surgical efficiency and deliver personalized solutions for better patient outcomes. Its knee replacement offerings include the Truliant Total Knee System, which recently expanded to include porous-coated implant options for non-cemented approaches. Furthermore, the company offers personalized solutions like the Optetrak Logic system, which aims for a custom fit. Exactech emphasizes strong R&D, customized planning systems, and a flexible approach to meet the diverse needs of surgeons across various market segments, establishing itself as an important and influential contributor to the orthopedic industry.
Enovis (DJO Global)
Enovis Corporation, which includes the DJO Global brand, has rapidly solidified its position in the orthopedics market, particularly after the acquisition and integration of LimaCorporate, which pushed its orthopedic sales over the $1 billion mark. Enovis is now a key competitor in the joint replacement devices market, leveraging its combined expertise to offer comprehensive hip, knee, and shoulder solutions. The company’s strategy involves blending clinical research with engineering to offer implants, such as the EMPOWR Hip and Knee systems, that emphasize wear resistance and improved patient mobility. Enovis also provides end-to-end solutions by having a strong presence in both implants and rehabilitation products, supporting both surgical and post-operative needs. The integration of LimaCorporate expanded DJO’s joint replacement channels internationally, ensuring a growing global market for its value-driven and accessible joint replacement options.
Medacta Group
Medacta Group SA, headquartered in Switzerland, is a specialized, innovation-driven company recognized for developing and commercializing orthopedic products, particularly in joint replacement. Medacta has consistently outpaced general market growth rates through a strong focus on minimal invasiveness, personalized medicine, and surgeon education. The company provides a full range of products for hip, knee, and spine applications. A highlight of their innovative portfolio is the NextAR Augmented Reality (AR) surgical platform, which supports surgeons in procedures for the knee and shoulder. Additionally, Medacta developed MyKnee R, a patient-specific set of 3D-printed blocks used to simplify the replacement of failed primary implants, demonstrating its commitment to advanced, personalized solutions and continuous technological refinement.
MicroPort Scientific
MicroPort Scientific Corporation, based in Shanghai, China, is a key global player in the joint replacement market, known for its focus on continuous innovation in minimally invasive implants. The company offers specialized orthopedic solutions through its subsidiary, MicroPort Orthopedics Holdings, aiming to improve patient outcomes in hip and knee replacements. MicroPort has made significant strides, particularly in the cementless total knee arthroplasty (TKA) segment, with products like the Evolution Medial-Pivot Knee System. Leveraging advanced manufacturing techniques, including 3D-printed constructs for complex anatomies, MicroPort focuses on adaptive solutions for diverse patient segments, particularly in the rapidly expanding Asia-Pacific market while also achieving global expansion. Its mission centers on partnering with healthcare professionals to deliver advanced, reliable hip and knee solutions.
Latest Market Research Report on Joint Replacement Devices Download PDF Brochure Now